Cargando…

Treatment with the herbal medicine, naoxintong improves the protective effect of high-density lipoproteins on endothelial function in patients with type 2 diabetes

The protective effect of high-density lipoprotein (HDL) on endothelial function is impaired in patients with type 2 diabetes mellitus (T2DM), which may result in atherosclerotic complications. Naoxintong (NXT) is a compound preparation that includes Radix Astragali, Angelicae sinensis, Radix Paeonia...

Descripción completa

Detalles Bibliográficos
Autores principales:	LV, PU, TONG, XUNLIANG, PENG, QING, LIU, YUANYUAN, JIN, HAIQIANG, LIU, RAN, SUN, WEI, PAN, BING, ZHENG, LEMIN, HUANG, YINING
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768949/ https://www.ncbi.nlm.nih.gov/pubmed/26781332 http://dx.doi.org/10.3892/mmr.2016.4792

Ejemplares similares

The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus
por: Tong, Xunliang, et al.
Publicado: (2014)

Apolipoprotein C-III in the high-density lipoprotein proteome of cerebral lacunar infarction patients impairs its anti-inflammatory function
por: Lv, Pu, et al.
Publicado: (2018)

High-density lipoprotein of patients with Type 2 Diabetes Mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate
por: Tong, Xunliang, et al.
Publicado: (2013)

Myocardial protective effect and transcriptome profiling of Naoxintong on cardiomyopathy in zebrafish
por: Hu, Mengyan, et al.
Publicado: (2021)

Specific DNA identification of Pheretima in the Naoxintong capsule
por: Zhu, Xiaoxiao, et al.
Publicado: (2019)

Meta-Analysis of Naoxintong Capsule for Patients with Vascular Dementia
por: Li, Li, et al.
Publicado: (2022)

Naoxintong accelerates diabetic wound healing by attenuating inflammatory response
por: Fang, Leyu, et al.
Publicado: (2021)

Protective effects of Naoxintong capsule alone and in combination with ticagrelor and atorvastatin in rats with Qi deficiency and blood stasis syndrome
por: Zhang, Wei-jian, et al.
Publicado: (2020)

Evaluation of the anti-inflammatory and antioxidant pharmcodynamic compoents of naoxintong capsules as a basis of broad spectrum effects
por: Lv, Bin, et al.
Publicado: (2021)

NaoXinTong Inhibits the Development of Diabetic Retinopathy in db/db Mice
por: Liu, Mengyang, et al.
Publicado: (2015)

NaoXinTong Capsules inhibit the development of diabetic nephropathy in db/db mice
por: Yang, Shu, et al.
Publicado: (2018)

Attenuating lipid metabolism in atherosclerosis: The potential role of Anti-oxidative effects on low-density lipoprotein of herbal medicines
por: Duan, Huxinyue, et al.
Publicado: (2023)

Naoxintong capsule delay the progression of diabetic kidney disease: A real-world cohort study
por: Zhang, Yuqing, et al.
Publicado: (2022)

Comparison of Risk Factor between Lacunar Stroke and Large Artery Atherosclerosis Stroke: A Cross-Sectional Study in China
por: Lv, Pu, et al.
Publicado: (2016)

Naoxintong Capsule Inhibits the Development of Cardiovascular Pathological Changes in Bama Minipig Through Improving Gut Microbiota
por: Zhang, Wei-jian, et al.
Publicado: (2019)

In Vitro Assessment of Cytochrome P450 2C19 Potential of Naoxintong
por: Chen, Hui, et al.
Publicado: (2012)

Naoxintong/PPARγ Signaling Inhibits Cardiac Hypertrophy via Activation of Autophagy
por: Yuan, Shuping, et al.
Publicado: (2017)

Development of activated endothelial targeted high-density lipoprotein nanoparticles
por: Yu, Minzhi, et al.
Publicado: (2022)

Naoxintong Retards Atherosclerosis by Inhibiting Foam Cell Formation through Activating PPARα Pathway
por: Wang, Zeng, et al.
Publicado: (2018)

Prevalence and risk factors of intracranial and extracranial artery stenosis in asymptomatic rural residents of 13 villages in China
por: Jin, Haiqiang, et al.
Publicado: (2017)

Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation
por: Wang, Yaqiong, et al.
Publicado: (2016)

Human Endothelial Progenitor Cells Internalize High-Density Lipoprotein
por: Srisen, Kaemisa, et al.
Publicado: (2013)

Anticipatory Role of High Density Lipoprotein and Endothelial Dysfunction: An Overview
por: Eren, Esin, et al.
Publicado: (2014)

Endothelial lipase increases antioxidative capacity of high-density lipoprotein
por: Schilcher, Irene, et al.
Publicado: (2019)

Herbal Medicine for Anxiety, Depression and Insomnia
por: Liu, Lei, et al.
Publicado: (2015)

Integrated metabolomics and gut microbiome to the effects and mechanisms of naoxintong capsule on type 2 diabetes in rats
por: Yan, Zenghao, et al.
Publicado: (2020)

Naoxintong Capsule Alternates Gut Microbiota and Prevents Hyperlipidemia in High-Fat-Diet Fed Rats
por: Lu, Yihang, et al.
Publicado: (2022)

An Energy Metabolism Study on the Efficacy of Naoxintong Capsules against Myocardial Infarction in a Rat Model
por: Zhao, Jie, et al.
Publicado: (2022)

Comparison of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol for the prediction of thin-cap fibroatheroma determined by intravascular optical coherence tomography
por: WANG, Yao, et al.
Publicado: (2020)

Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration
por: Zhou, Boda, et al.
Publicado: (2017)

The effects of herbal medicine on epilepsy
por: Liu, Wei, et al.
Publicado: (2017)

Efficacy and safety of Naoxintong capsule for acute ischemic stroke: A protocol for systematic review and meta-analysis
por: Li, Na, et al.
Publicado: (2021)

The effectiveness and safety of Naoxintong capsules in the treatment of vascular dementia: A protocol for systematic review and meta-analysis
por: Li, Yan-Lin, et al.
Publicado: (2021)

High-density lipoprotein exerts vasculoprotection via endothelial progenitor cells
por: Petoumenos, Vasileios, et al.
Publicado: (2009)

Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction
por: Abdo, Adrian I., et al.
Publicado: (2017)

Comparison of Mechanisms of Endothelial Cell Protections Between High-Density Lipoprotein and Apolipoprotein A-I Mimetic Peptide
por: Xu, Wenqi, et al.
Publicado: (2019)

Epigenetic Studies of Chinese Herbal Medicine: Pleiotropic Role of DNA Methylation
por: Guo, Wenqian, et al.
Publicado: (2021)

Low density lipoprotein mimics insulin action on autophagy and glucose uptake in endothelial cells
por: Zhu, Lin, et al.
Publicado: (2019)

Novel function of fluvastatin in attenuating oxidized low-density lipoprotein-induced endothelial cell ferroptosis in a glutathione peroxidase4- and cystine-glutamate antiporter-dependent manner
por: Li, Qing, et al.
Publicado: (2021)

Rosuvastatin protects against oxidized low-density lipoprotein-induced endothelial cell injury of atherosclerosis in vitro
por: Geng, Jianan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a0t7pmsshicd9deo0jmie2p3rc